This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Leland Stanford Junior University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Harrison P. Rahn: Inventor of a Dendrimer-Based Therapeutic Approach.
Introduction
Harrison P. Rahn is an inventor based in Redwood City, California, and is associated with Leland Stanford Junior University. His patent work concerns therapeutic compounds designed to deliver cargo to cells, with particular attention to potential applications against bacterial infections.
Latest Patents
Rahn is named on 1 patent: “Composition and Method for New Therapeutic Agents Including Guanidinium-Presenting Dendrimers and Branched Structures.” The patent describes the design, synthesis, and biological evaluation of conjugate compounds incorporating dendrimeric components and branched structures. It also covers pharmaceutical compositions and methods for delivering cargo molecules to cells.
The disclosed methods include applications intended to reduce bacterial populations and, in certain embodiments, eradicate Gram-positive bacteria, mycobacteria, Gram-negative bacteria, or bacterial biofilms. The patent also describes using the compounds to treat diseases or conditions, including infectious diseases.
Career Highlights
A central feature of Rahn’s patent is its focus on combining dendrimeric structures with therapeutic cargo. The invention outlines a platform for investigating how these conjugates may interact with cells and support potential antimicrobial treatments.
Collaborations
The patent information associates Rahn with Leland Stanford Junior University. The available details identify this institutional connection but do not specify individual collaborators.
Conclusion
Harrison P. Rahn’s patent documents a dendrimer-based therapeutic approach with proposed applications in cargo delivery and the treatment of bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
